Literature DB >> 14160246

TO-DAY'S DRUGS. INDOMETHACIN.

P B GUYER.   

Abstract

Entities:  

Keywords:  TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14160246      PMCID： PMC1815987     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  THE METABOLITES OF INDOMETHACIN, A NEW ANTI-INFLAMMATORY DRUG.

Authors:  R E HARMAN; M A MEISINGER; G E DAVIS; F A KUEHL
Journal:  J Pharmacol Exp Ther       Date:  1964-02       Impact factor: 4.030

2.  INDOMETHACIN.

Authors:  F D HART; P L BOARDMAN
Journal:  Practitioner       Date:  1964-06

3.  INDOMETHACIN IN RHEUMATIC DISEASES. A CONTROLLED CLINICAL TRIAL.

Authors:  J WANKA; L I JONES; P H WOOD; A S DIXON
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

4.  INDOMETHACIN IN THE TREATMENT OF RHEUMATIC DISEASES.

Authors:  J S PERCY; P STEPHENSON; M THOMPSON
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

5.  ANTI-INFLAMMATORY AND ANTIPYRETIC ACTIVITIES OF INDOMETHACIN, 1-(P-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETIC ACID.

Authors:  C A WINTER; E A RISLEY; G W NUSS
Journal:  J Pharmacol Exp Ther       Date:  1963-09       Impact factor: 4.030
  5 in total
  2 in total

Review 1.  When indomethacin fails: additional treatment options for "indomethacin responsive headaches".

Authors:  Shuhan Zhu; Brian McGeeney
Journal:  Curr Pain Headache Rep       Date:  2015-03

2.  Indomethacin attenuates mechanical allodynia during the organization but not the maintenance of the peripheral neuropathic pain induced by nervus ischiadicus chronic constriction injury.

Authors:  P Medeiros; I R Dos Santos; A C Medeiros; J A da Silva; S H Ferreira; R L de Freitas; N C Coimbra
Journal:  Braz J Med Biol Res       Date:  2020-04-27       Impact factor: 2.590
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.